Phase
Condition
Knee Replacement
Treatment
AMF TT cones
Multigen Plus CCK
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female.
Age ≥ 18 years old.
Given written informed consent approved by the reference Ethics Committee (EC).
Subjects in whom a decision has already been made to perform a Total KneeArthroplasty with Multigen Plus system as per Indication For Use. The decision toimplant a Multigen Plus CCK system, alone or involving the AMF TT cones, must betaken prior to, and independently from, the decision to enrol the subject. Thisdecision should be made in accordance with routine clinical practice at the studysite concerned.
Subjects able to comply with the Study Protocol.
Exclusion
Exclusion Criteria:
Age < 18 years old.
Subjects with any Multigen Plus system contraindication for use, or any AMF TT conescontraindication for use when used in combination with the Multigen Plus CCK, asreported in the current Instruction For Use.
Any clinically significant pathology based on the medical history that theInvestigator feels may affect the study evaluation.
Female subjects who are pregnant, nursing, or planning a pregnancy.
Previous knee replacement on the contralateral side within the last year and whoseoutcome is achieving an KSS < 70 points.
Study Design
Study Description
Connect with a study center
Hospital Senhora da Oliveira in Guimarães
Guimarães,
PortugalActive - Recruiting
Saints Cyril and Methodius Hospital
Bratislava,
SlovakiaActive - Recruiting
Royal Devon and Exeter Hospital
Exeter,
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.